Seoul, South Korea

Kyung-Sik Lee

This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyung-Sik Lee. Retrieved from https://idiyas.com/inventor/kyung-sik-lee-mkpju6d5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Kyung-Sik Lee in Dementia Treatment

Introduction

Kyung-Sik Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dementia. His innovative work focuses on the development of compounds that can enhance cognitive functions.

Latest Patents

Kyung-Sik Lee holds a patent for "Ferulic acid dimers and their pharmaceutically acceptable salts, their preparation and use thereof for treating dementia." This invention relates to ferulic acid dimers and their salts, which have shown excellent effects on learning and memory retention abilities in vivo. The potential applications of this invention could greatly benefit individuals suffering from dementia.

Career Highlights

Kyung-Sik Lee is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Some of his notable coworkers include Kye-Jung Shin and Dong-Jin Kim, who contribute to the collaborative efforts in research and innovation within the institute.

Conclusion

Kyung-Sik Lee's contributions to dementia treatment through his innovative patent highlight the importance of research in improving cognitive health. His work exemplifies the potential of scientific advancements in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…